Industry-Supported Symposia
These are not official programs of the American College of Rheumatology.
Events
Preventing Progression in Lupus: Are You Intervening Early Enough?
Regency Ballroom Q – Hyatt
Developed and offered by GSK
Making Waves in axSpA and HS: Connecting Diseases Through Shared Immune Pathways
Windmere Ballroom X
Developed and offered by UCB Medical
Reframing Sjögren’s Disease: Patient perspectives and clinical context in a systemic and often progressive disease
Windermere Y
Developed and offered by Novartis Pharmaceuticals Corporation
Connecting the Evidence: Translational Science, Clinical Trials, and Real-World Data in SLE
Regency Ballroom P
Developed and offered by AstraZeneca.
The Pathogenesis of Sjögren’s Disease and Clinical Pearls on Diagnosis
Windermere Ballroom W
Developed and offered by Johnson & Johnson.
Beyond the Joints: A Whole-Body Approach to Psoriatic Arthritis Care Through Integrated Obesity Management
Orlando Ballroom N
Provided by Clinical Care Options LLC dba Decera Clinical Education in partnership with the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and Obesity Medicine Association (OMA). This activity is supported by an educational grant from Lilly.
Suspect. Detect. Act: Diagnosing and Treating Autoimmune Interstitial Lung Disease
Windermere Ballroom Z
Developed and offered by Boehringer Ingelheim Pharmaceuticals, Inc.
Beyond the Joint: The Immunometabolic Burden of Obesity in Knee OA
Regency Ballroom P
Developed and offered by Eli Lilly and Company
Autoimmune Myositis Reframed: New Perspectives on Burden, Biology, and Clinical Outcomes
Regency Ballroom Q
Developed and offered by argenx.
A Closer Look at Psoriatic Arthritis With Axial Involvement
Windermere Ballroom W
Developed and offered by Johnson & Johnson.
Turning Complexity Into Clinical Clarity: Practical Approaches for the Comprehensive Assessment of Sjögren’s Disease
Windermere Ballroom X
Developed and offered by Novartis Pharmaceuticals Corporation.
Reframing Lupus Care: Emerging TYK2 Inhibitors and the Future of Treat-to-Target Management in SLE
Regency Ballroom O
Developed and offered by Bristol Myers Squibb.
Every Conversation Counts: Achieving Disease Control Across the Reproductive Journey in Women With SLE
Windermere Ballroom Y
Developed and offered by UCB Biopharma SRL.
Treatment Advances in IgG4-Related Disease: Integrating Targeted Therapy to Improve Patient Outcomes
Regency Ballroom Q
Developed and offered by Med Learning Group. Supported by Amgen.
Imagine What’s Next in Myositis Care: Integrating Targeted Strategies to Advance Patient Outcomes
Regency Ballroom P
Developed and offered by PeerView Institute for Medical Eduation. Supported by argenx.
A Key Source of the Signal: Rethinking Lupus Skin and Joint Disease
Windermere Ballroom W
Developed and offered by Biogen.
Lupus Nephritis: New Treatments to Improve Patient Outcomes
Orlando Ballroom N
Developed and offered by Vindico. Supported by Genentech, a member of the Roche Group.
A Multidisciplinary Journey Through SLE Heterogeneity
Regency Ballroom O
Developed and offered by Viatris.
Targeting Upstream in Sjögren Disease: Building a Deeper Understanding of Disease and Investigational Therapies
Windermere Ballroom Z
Developed and offered by Vor Bio.
IgG4-RD in Focus: From Disease Burden to Emerging Clinical Evidence
Windermere Ballroom Y
Developed and offered by Zenas BioPharma.